Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: HEXAMER THERAPEUTICS INC.
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2023-09-29 to 2025-11-28
Current total value of award: $3928061.02
Description: RESEARCH AND DEVELOPMENT SERVICES BA230121 TITLED SELF ASSEMBLING VACCINE PLATFORM